World's Best Scientists 2026 revealed!
Mathias Heikenwalder

Mathias Heikenwalder

D-Index & Metrics

Immunology

D-Index
106
Citations
46514
World Ranking
559
National Ranking
31

Medicine

D-Index
106
Citations
46515
World Ranking
6466
National Ranking
367

Mathias Heikenwalder publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mathias Heikenwalder sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 366 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mathias Heikenwalder D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mathias Heikenwalder sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 106 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2019 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Human Genetics and Molecular Medicine

Overview

Mathias Heikenwalder is affiliated with the German Cancer Research Center in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to subfields including Molecular Biology, Immunology, Epidemiology, Oncology, and Hepatology.

The scientist's work has focused extensively on liver diseases and cancer, exploring topics such as:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immune Cell Function and Interaction

Mathias Heikenwalder has published in several notable venues, often contributing to journals specializing in hepatology and cancer research. Frequent publication venues include:

  • Journal of Hepatology
  • Zeitschrift für Gastroenterologie
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature

Recent papers reflect a focus on liver cancer, inflammation, and immunological mechanisms, with titles and publication details such as:

  • Immunotherapies for hepatocellular carcinoma, 2021, Nature Reviews Clinical Oncology
  • The immunological and metabolic landscape in primary and metastatic liver cancer, 2021, Nature reviews. Cancer
  • Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits, 2022, Journal of Hepatology
  • Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH, 2021, Nature
  • SpaceM reveals metabolic states of single cells, 2021, Nature Methods

The scientist has collaborated frequently with other researchers, including:

  • Danijela Heide
  • Suchira Gallage
  • Tobias Riedl
  • Mohammad Rahbari
  • Thomas F. Baumert

Mathias Heikenwalder was recognized by election to the German National Academy of Sciences Leopoldina in 2019, specifically highlighting contributions in Human Genetics and Molecular Medicine.

Best Publications

  • Immunotherapies for hepatocellular carcinoma.

    Josep M Llovet;Josep M Llovet;Josep M Llovet;Florian Castet;Mathias Heikenwalder;Mala K Maini

  • Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

    Tae-Won Kang;Tetyana Yevsa;Norman Woller;Lisa Hoenicke

  • Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways

    Katrin Kierdorf;Daniel Erny;Tobias Goldmann;Victor Sander

  • From NASH to HCC: current concepts and future challenges.

    Quentin M Anstee;Quentin M Anstee;Helen L Reeves;Helen L Reeves;Elena Kotsiliti;Olivier Govaere

  • The maternal microbiota drives early postnatal innate immune development

    Mercedes Gomez de Agüero;Stephanie C. Ganal-Vonarburg;Tobias Fuhrer;Sandra Rupp

  • Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

    Alexander Mildner;Hauke Schmidt;Mirko Nitsche;Doron Merkler

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

    Julie Lucifora;Yuchen Xia;Florian Reisinger;Ke Zhang

  • The immunology of hepatocellular carcinoma.

    Marc Ringelhan;Dominik Pfister;Tracy O'Connor;Eli Pikarsky

  • Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses

    Siegfried Hapfelmeier;Melissa A.E. Lawson;Emma Wetter Slack;Jorum K. Kirundi

  • mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

    Nicolás Herranz;Suchira Gallage;Massimiliano Mellone;Torsten Wuestefeld

  • NAFLD causes selective CD4 + T lymphocyte loss and promotes hepatocarcinogenesis

    Chi Ma;Aparna H. Kesarwala;Tobias Eggert;José Medina-Echeverz

  • A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation

    Tobias Goldmann;Peter Wieghofer;Philippe F Müller;Yochai Wolf

  • Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes

    Monika Julia Wolf;Arlind Adili;Kira Piotrowitz;Zeinab Abdullah

  • Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis

    Yvonne S. Eisele;Ulrike Obermüller;Ulrike Obermüller;Götz Heilbronner;Götz Heilbronner;Frank Baumann;Frank Baumann

  • Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression

    Tobias Eggert;Katharina Wolter;Juling Ji;Chi Ma

  • The immunological and metabolic landscape in primary and metastatic liver cancer

    Xin Li;Pierluigi Ramadori;Dominik Pfister;Marco Seehawer

  • Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

    Mathias Heikenwalder;Magdalini Polymenidou;Tobias Junt;Christina Sigurdson

  • The Salmonella Pathogenicity Island (SPI)-2 and SPI-1 Type III Secretion Systems Allow Salmonella Serovar typhimurium to Trigger Colitis via MyD88-Dependent and MyD88-Independent Mechanisms

    Siegfried Hapfelmeier;Bärbel Stecher;Manja Barthel;Marcus Kremer

  • Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma

    Marta Garnelo;Alex Tan;Zhisheng Her;Joe Yeong;Joe Yeong

  • A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma

    Johannes Haybaeck;Nicolas Zeller;Monika Julia Wolf;Achim Weber

Frequent Co-Authors

Achim Weber
Achim Weber University of Zurich
Ulrike Protzer
Ulrike Protzer Technical University of Munich
Percy A. Knolle
Percy A. Knolle Technical University of Munich
Adriano Aguzzi
Adriano Aguzzi University of Zurich
Marco Prinz
Marco Prinz University of Freiburg
Lars Zender
Lars Zender German Cancer Research Center
Roland Rad
Roland Rad Technical University of Munich
Christian Trautwein
Christian Trautwein RWTH Aachen University
Josep M. Llovet
Josep M. Llovet University of Barcelona
Petra Schwarz
Petra Schwarz University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to a variety of careers in healthcare and research, but many students also explore related fields for expanded opportunities. For those interested in nursing, understanding the range of educational options is essential. For example, if you are considering a quicker route to becoming a nurse, exploring programs like the easiest absn programs to get into can provide valuable insights into accelerated entry points.

Alternatively, practical nursing roles continue to be in high demand. Prospective students often look into lpn programs with easiest admission requirements to find approachable pathways into the field. These programs can serve as stepping stones towards advanced practice roles.

For those aiming higher in clinical practice, pursuing nurse practitioner education is a logical next step. Identifying the what is the easiest np program helps learners locate the most accessible NP degrees, facilitating smoother progression in their careers.

Specialized fields like psychiatric mental health nursing are critical in healthcare. Students interested in this specialization should consider programs with strong clinical support, such as the best online psychiatric mental health nurse practitioner programs, which offer excellent clinical placement rates to ensure practical experience and success.

Best Scientists Citing Mathias Heikenwalder

Trending Scientists

Recently Published Articles